PFG
ABBV icon

PAX Financial Group’s AbbVie ABBV Stock Holding History

PAX Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
2,019
+123
+6% +$26.5K 0.08% 123
2026
Q1 		$412K Sell
1,896
-339
-15% -$75.2K 0.07% 134
2025
Q4 		$511K Sell
2,235
-235
-10% -$53.5K 0.09% 120
2025
Q3 		$572K Buy
2,470
+95
+4% +$19.3K 0.1% 126
2025
Q2 		$441K Sell
2,375
-356
-13% -$66.2K 0.08% 158
2025
Q1 		$572K Buy
2,731
+592
+28% +$115K 0.1% 159
2024
Q4 		$380K Buy
2,139
+251
+13% +$46.1K 0.07% 191
2024
Q3 		$373K Buy
1,888
+289
+18% +$53.9K 0.07% 191
2024
Q2 		$274K Buy
1,599
+409
+34% +$67.8K 0.05% 210
2024
Q1 		$217K Buy
+1,190
New +$205K 0.04% 216

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PAX Financial Group's ABBV Position: Q2 2026 in Review

PAX Financial Group increased its AbbVie (ABBV) stake by 6.5% in Q2 2026, buying an estimated $26.5K and bringing the position to 2,019 shares worth $508K. The position accounts for 0.08% of the portfolio, ranked #123.

PAX Financial Group first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $572K in Q1 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PAX Financial Group held 2,019 shares of AbbVie worth $508K as of Q2 2026.
  • PAX Financial Group bought 123 AbbVie shares in Q2 2026, an estimated $26.5K.
  • AbbVie made up 0.08% of PAX Financial Group's portfolio in Q2 2026, its #123 holding.
  • PAX Financial Group first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • PAX Financial Group's AbbVie position peaked at $572K in Q1 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PAX Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.